-
Skyhawk’s drug trial takes flight in the US
4 min read
Latest News
-
Oz Buzz Video: Day 1
32 min read
Day 1 of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011
-
Oz Buzz Updates: Day 3
5 min read
Day 3 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-
Oz Buzz Updates: Day 2
6 min read
Day 2 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-
Oz Buzz Updates: Day 1
4 min read
Day 1 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-
Stand By for Oz Buzz
3 min read
Follow @HDBuzzFeed and send your questions for the World Congress on Huntington's disease
-
Ten golden rules for reading a scientific news story
8 min read
Avoid the hype: HDBuzz presents ten 'golden rules' for reading a news story or press release about Huntington's disea
-
Protein-folding drug helps HD mice… for a while
6 min read
A drug that activates an ancient cellular defense mechanism slows down HD in mice – but why didn’t the benefit last?
-
A back-to-front hidden message in the HD gene?
7 min read
Unzip your genes! A backwards message, hidden in the 'backup DNA' of the Huntington's disease gene… what does it me
-
Stem cells and HD: past, present and future
11 min read
Stem cells – who needs 'em? Scientists make brain cells from skin cells. Could this help HD?
-
Coming soon from the HD World Congress: Oz Buzz!
4 min read
Announcing 'Oz Buzz' – hot science news from the 2011 HD World Congress – with Ed Wild, Jeff Carroll & Charles Sabine
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
